Table 1.
Patient characteristics
| Characteristic | Entire population (n=82) |
|
| N | % | |
| Sex | ||
| Female | 39 | 47.8 |
| Male | 43 | 52.4 |
| Age, years | ||
| ≤50 | 36 | 43.9 |
| >50 | 46 | 56.1 |
| Grade | ||
| WHO Ⅱ | 30 | 36.6 |
| WHO Ⅲ | 27 | 32.9 |
| WHO Ⅳ | 25 | 30.5 |
| Histology | ||
| Astrocytoma | 37 | 45.1 |
| Oligodendroglioma | 14 | 17.1 |
| Glioblastoma | 22 | 26.8 |
| Gliosarcoma | 4 | 4.9 |
| Mixed glioma | 5 | 6.1 |
| Extend of resection | ||
| Complete resection | 69 | 84.1 |
| Subtotal resection | 13 | 15.9 |
| Type of postoperative first-line therapy (TMZ or radiotherapy) | ||
| Yes | 54 | 65.9 |
| No | 28 | 34.1 |
| Alive at last follow-up | ||
| Yes | 21 | 25.6 |
| No | 54 | 65.9 |
| Unknown | 7 | 8.5 |
| Median overall survival in days (range) | 390 (61–2178) | |
TMZ, temozolomide.